Critical appraisal of bepotastine in the treatment of ocular itching associated with allergic conjunctivitis

Jeremy B Wingard, Francis S MahUPMC Eye Center, Department of Ophthalmology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USAAbstract: Bepotastine besilate 1.5% solution is an H1-antihistamine recently approved by the Food and Drug Administration for the topical treatment of ocular i...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Jeremy B Wingard, Francis S Mah
Format: article
Langue:EN
Publié: Dove Medical Press 2011
Sujets:
Accès en ligne:https://doaj.org/article/19e368d1c9334adc98c1108334b34dd1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!